Market revenue in 2023 | USD 170.1 million |
Market revenue in 2030 | USD 299.2 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Pharmaceutical industry was the largest segment with a revenue share of 43.27% in 2023. Horizon Databook has segmented the Saudi Arabia in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
The in vitro toxicology testing market in Saudi Arabia is still developing and is expected to grow due to increasing demand for safety assessment of chemicals and drugs. The Saudi Arabian government has been focusing on developing its healthcare infrastructure and promoting clinical research, which is expected to contribute to the growth of the market.
Moreover, the increasing incidence of chronic diseases such as cancer and cardiovascular diseases is expected to drive demand for new drugs and therapies, which in turn is expected to boost the demand for in vitro toxicology testing.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account